FOREMOST: Apremilast in Early Oligoarticular Psoriatic Arthritis A controlled trial has shown that apremilast is effective in patients with early, oligoarticular psoriatic arthritis (PsA). https://t.co/i2w4RbGd5f https://t.co/5PD6pYB5vm